25.11.2014 Views

Biostatistics

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

8.6 SUMMARY 373<br />

Percent Change in CD4 T Cell Treatment Plasma<br />

77.30 1 1<br />

0:44 1 1<br />

50.20 1 1<br />

48.60 2 2<br />

86.20 2 2<br />

205.80 1 2<br />

100.00 1 2<br />

34.30 1 2<br />

82.40 1 2<br />

118.30 1 2<br />

Source: Data provided courtesy of Simona Porcellini, Guiliana Vallanti,<br />

Silvia Nozza, Guido Poli, Adriano Lazzarin, Guiseppe Tabussi,<br />

and Antonio Grassia, “Improved Thymopoietic Potential in Aviremic<br />

HIV Infected Individuals with HAART by Intermittent IL-2<br />

Administration,” AIDS, 17 (2003), 1621–1630.<br />

8.5.5. A study by Gorecka et al. (A-26) assessed the manner in which among middle-aged smokers the<br />

diagnosis of airflow limitation (AL) combined with advice to stop smoking influences the smoking<br />

cessation rate. Their concerns were whether having AL, whether the subject successfully quit<br />

smoking, and whether interaction between AL and smoking status were significant factors in regard<br />

to baseline variables and lung capacity variables at the end of the study. Some of the variables of<br />

interest were previous years of smoking (pack years), age at which subject first began smoking,<br />

forced expiratory volume in one second ðFEV 1 Þ, and forced vital capacity (FVC). There were 368<br />

subjects in the study. What are the factors in this study? At how many levels does each occur? Who<br />

are the subjects? What is (are) the response variable(s)? Can you think of any extraneous variables<br />

whose effects are included in the error term?<br />

8.5.6. A study by Meltzer et al. (A-27) examined the response to 5 mg desloratadine, an H1-receptor<br />

antagonist, in patients with seasonal allergies. During the fall allergy season, 172 subjects were<br />

randomly assigned to receive treatments of desloratadine and 172 were randomly assigned to receive<br />

a placebo. Subjects took the medication for 2 weeks after which changes in the nasal symptom score<br />

were calculated. A significant reduction was noticed in the treatment group compared to the placebo<br />

group, but gender was not a significant factor. What are the factors in the study? At how many levels<br />

does each occur? What is the response variable?<br />

8.6 SUMMARY<br />

The purpose of this chapter is to introduce the student to the basic ideas and techniques of<br />

analysis of variance. Two experimental designs, the completely randomized and the<br />

randomized complete block, are discussed in considerable detail. In addition, the concept<br />

of repeated measures designs and a factorial experiment as used with the completely<br />

randomized design are introduced. Individuals who wish to pursue further any aspect of<br />

analysis of variance will find the methodology references at the end of the chapter most<br />

helpful.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!